Results 61 to 70 of about 6,623 (181)

Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model

BMC Infectious Diseases, 2017
Background Tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccination during adolescence was introduced in response to the resurgence of pertussis in various countries.
Hyo Jin Kwon, Seung Beom Han, Bo Ram Kim, Kyu Ri Kang, Dong Ho Huh, Gi Sub Choi, Dong Ho Ahn, Jin Han Kang   +7 more
doaj   +1 more source

Pertussis Immunization for Adolescents: What Are We Waiting for?

Canadian Journal of Infectious Diseases, 2001
Immunization against pertussis (whooping cough) has been part of the routine childhood immunization program for over 50 years. Until 1997, a whole cell pertussis vaccine was used, most often combined with diphtheria and tetanus toxoids; in some ...
SA Halperin
doaj   +1 more source

Replacing ADT With dTpa in Queensland Emergency Departments: Another Opportunity for Pertussis Control?

Emergency Medicine Australasia, Volume 38, Issue 1, February 2026.
Michael D. Nissen, Faye Jordan, Polash Adhikari, Sebastian Vernal, Luis Furuya‐Kanamori   +4 more
wiley   +1 more source

Cellular and Acellular Pertussis Vaccines in Adults [PDF]

Clinical Infectious Diseases, 1999
Immunization against pertussis after childhood previously was considered unnecessary, because severe illness and complications rarely developed in older persons. The rising incidence of pertussis among older adolescents and adults and the transmission of infection from adults to infants suggest that booster immunization may be necessary to more ...
openaire   +2 more sources

The Role of the Aceullular Pertussis Vaccine and the Comeback of 'Pertussis Pete'?

Canadian Journal of Infectious Diseases, 2001
Pertussis or whooping cough is an acute infectious disease of the respiratory tract caused principally by Bordetella pertussis and less commonly by Bordetella parapertussis (1).
John M Conly, B Lynn Johnston
doaj   +1 more source

Evaluation of acellular pertussis vaccine: comparisons among different strains of mice. [PDF]

Emerg Microbes Infect, 2023
Wei J, Guang J, Wei C, Wang H, Zhou J, Li H, Wang L, Ma X, Yue B.   +8 more
europepmc   +1 more source

Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants. [PDF]

Emerg Microbes Infect, 2023
Knuutila A, Barkoff AM, Ivaska L, Tenhu E, Teräsjärvi J, van Gageldonk P, Buisman A, Mertsola J, He Q, PERISCOPE consortium.   +9 more
europepmc   +1 more source

Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy. [PDF]

Med Princ Pract, 2022
Alghounaim M, Alsaffar Z, Alfraij A, Bin-Hasan S, Hussain E.   +4 more
europepmc   +1 more source

Pertactin deficiency of Bordetella pertussis: Insights into epidemiology, and perspectives on surveillance and public health impact

Human Vaccines & Immunotherapeutics
Pertussis resurgence has been documented even in countries with high pediatric vaccine coverage. The proportion of Bordetella pertussis isolates not expressing pertactin (PRN) has increased in several countries where acellular pertussis (aP) vaccines are
Ulrich Heininger, Helena Martini, Jennifer Eeuwijk, Ivana Prokić, Adrienne P. Guignard, Elisa Turriani, Maurine Duchenne, Valérie Berlaimont   +7 more
doaj   +1 more source

Estimating Population-Level Effects of the Acellular Pertussis Vaccine Using Routinely Collected Immunization Data. [PDF]

Clin Infect Dis, 2021
Rane MS, Halloran ME.
europepmc   +1 more source